High Quality Services from BioCrypton and CMS
Cureline Groups members, BioCrypton, Inc., and Cureline Molecular Services LLC, provide access to uniquie glycosylation detection technology (licesed from Caltech) in order to investigate novel biomarkers.
Please contact BioCrypton and CMS Services if interested.